Pharmaids Pharmaceuticals Ltd — Others, 21-08-2025: Others

Pharmaids Pharmaceuticals' board has approved the audited financial statements for the fiscal year ended March 31, 2025, along with the Board's Report and Corporate Governance Report. The notice for the 36th Annual General Meeting, to be held via virtual means, was cleared, and CS Kashinath Sahu was appointed as the e-voting scrutinizer. The board also cleared the continuation of Independent Director Mr. P. N. Vijay's directorship, pending shareholder approval. Additionally, CS Kashinath Sahu & Co was appointed as the Secretarial Auditor for five years, also subject to shareholder approval at the AGM. These steps finalize annual reporting and set the stage for key shareholder decisions.